Tissue plasminogen activator is the first and only drug approved by the FDA in 1996 for the treatment of acute ischemic stroke.

Lack of awareness among the populace is a major problem leading to health problems that can be easily avoided through proper medical adherence.

Increasing geriatric population and rise in adoption of enteral feeding devices will drive the overall immunotherapy drugs market

Crohn’s disease is a form of inflammatory bowel disease (IBD) that refers to a chronic inflammatory condition of the gastrointestinal tract causing inflammation in the digestive tract.

According to a study published in the British Journal of Dermatology in 2015, 9.4% of global population was estimated to be affected by acne.

Cancer is the disease in which cell grows abnormally and may cause a tumor.

High funding for research and development and clinical trials drugs to boost the tuberculosis drugs market.

Based on this technique, three types of blood irradiation are available in the market i.e. intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation.

Increasing number of hip and knee replacement surgeries are augmenting rivaroxaban market growth

Newborn screening tests look for developmental, metabolic, and genetic disorders in infants.

Low investment cost and high accessibility to healthcare facilities are major factors driving growth of the micro-hospitals market

Immune system of haemophilia patients’ produces antibodies called as inhibitors, which acts against the administered therapy.

Point-of-care diagnostic devices and high cost of the wearable biosensor devices are the factors restraining market growth.

Large volume parenteral comes in bag or bottle for intravenous administration and are used for correction of fluid/electrolyte balance, providing nutrition such as dextrose.

The most common types of glaucoma are Primary Open Angle Glaucoma (POAG) and Primary Angle Closure Glaucoma (PACG).

Increasing launches of novel drugs for treatment of drug abuse in market is expected to drive the global drug abuse treatment market growth in near future.

Tissue plasminogen activator is the first and only drug approved by the FDA in 1996 for the treatment of acute ischemic stroke.

Healthcare facilities are looking forward to expand their facilities with advanced technologies to create innovative and cost-effective solutions to address barriers to universal vaccination

Technological advancements in cancer treatments such as chemotherapy and rising investment in cancer care are reducing the number of cancer deaths worldwide.

E-cigarettes are effective in reducing tobacco related health conditions, while NRTs work best for smoking cessation.

Global H1N1 vaccine market has presence of both multinational pharmaceutical companies and companies from emerging economies.

Combination treatment in aesthetics consists of multiple treatment approaches for improving aesthetic appearance for consumer.

The most widely used treatment for NASH is to eliminate potential causes and risk factors such as weight loss and treatment for hyperglycemia or dyslipidemia.

Increasing number of pipeline drugs for treating wounds and thrombosis can propel the growth of plasminogen activator inhibitor market

Cancer biomarkers are biological molecule produced either by tumor cells or by human tissues in response to cancer.

Limited options of cancer metabolism targeting therapies are expected provide potential opportunities for development of novel cancer metabolism-based therapeutics in the near future.

Streptozocin is a drug approved by U.S. Food and Drug Administration (USFDA) for the treatment of pancreatic islet cells cancer.

Adipose derived stem cells are gaining appeal as a new cell source in regenerative medicine therapies as it can be differentiated into a variety of different cell lineages.

Several monoclonal antibodies to treat inflammatory, cancer, and other diseases have been approved by the U.S. Food & Drug Administration (FDA).

The subsidiary firm by Johnson Company in USA developed IBOT, a stair climbing wheelchair. The price of IBOT was so high that most of people could not afford it and it was discontinued in 2009.

Sinus Dilation Devices market are focused on launching novel catheters in order to reduce nasal sinusitis or sinuses and address the critical unmet needs of patients.

Increasing incidents of minor injuries from sports activities that lead to muscle pain is also expected to contribute to the Kinesio Tape market growth.

Launch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth.

Growing Research and Development Funding from Various Government and Private Organizations is one of the Key Factors Driving Growth of the Market.

Rising incidences of cardiac disorders worldwide is expected to drive the cardiac rhythm management devices market revenue

Increasing cases of prostate cancers, injuries, and medical conditions requiring urethral stents, dilators, and catheters is one of the major factors for rise in urethral stricture cases,

Increasing number of sport injuries including fractures and bone dislocation is expected to boost demand for portering chairs.

Increasing incidence of fracture due to osteoporosis would be major reason for growth of the bone sonometer market.

Increasing research and development activities for discovering new medicine using sucralfate is expected to propel growth of the sucralfate market.

Pneumococcal Vaccines Market Analysis & Outlook By Leading Players Pfizer, Inc., Merck & Co. Inc., and GlaxoSmithKline plc.

Increasing awareness amongst parent about this disorder, and improvement of psychotic and medication treatment.

Gene synthesis is chemically in vitro synthesis of double-stranded DNA molecules.

Respiratory air conditioning devices artificially modifies air for its humidity content and temperature before it is inhaled by the patient.

Increasing number of product launches, in order to improve the ability for correcting refractive errors is expected to drive the market growth.

Various research companies are targeting synthetic CpG ODN due to the type I pro-inflammatory response it produces and its successful use as vaccine adjuvants.

High demand for livestock and increased consumption of milk, beef, and other food products.

Increasing number of cardiology and neurological diseases worldwide is expected to drive growth of the intraoperative monitoring electrodes market.

The global oncology drugs market size is estimated to be valued at US$ 77.3 billion in 2018 and is expected to witness a CAGR of 12.3% over the forecast period (2018–2026).

Poliomyelitis is an acute communicable disease of humans caused by human enterovirus called poliovirus.

The global liver fibrosis treatment market size is expected to witness a CAGR of 10.8% over the forecast period (2018–2026) reaching a value of US$ 28.1 billion in 2026.